GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo.
Chimento A, Sirianni R, Casaburi I, Zolea F, Rizza P, Avena P, Malivindi R, De Luca A, Campana C, Martire E, Domanico F, Fallo F, Carpinelli G, Cerquetti L, Amendola D, Stigliano A, Pezzi V.
Chimento A, et al. Among authors: rizza p.
Oncotarget. 2015 Aug 7;6(22):19190-203. doi: 10.18632/oncotarget.4241.
Oncotarget. 2015.
PMID: 26131713
Free PMC article.